These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2023757)

  • 1. Clinical doxorubicin chemomyectomy. An experimental treatment for benign essential blepharospasm and hemifacial spasm.
    Wirtschafter JD
    Ophthalmology; 1991 Mar; 98(3):357-66. PubMed ID: 2023757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm and hemifacial spasm.
    Wirtschafter JD; McLoon LK
    Ophthalmology; 1998 Feb; 105(2):342-6. PubMed ID: 9479297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemomyectomy of the orbicularis oculi muscles for the treatment of localized hemifacial spasm.
    Wirtschafter JD
    J Neuroophthalmol; 1994 Dec; 14(4):199-204. PubMed ID: 7881523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin protects the eyelid skin from injury after injection of doxorubicin.
    McLoon LK; Ozel B; Wirtschafter J
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1433-40. PubMed ID: 7775121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of blepharospasm with botulinum toxin. A preliminary report.
    Frueh BR; Felt DP; Wojno TH; Musch DC
    Arch Ophthalmol; 1984 Oct; 102(10):1464-8. PubMed ID: 6385932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion.
    Carruthers J; Stubbs HA
    Can J Neurol Sci; 1987 Feb; 14(1):42-5. PubMed ID: 3815164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of blepharospasm and facial hemispasm by injection of botulinum toxin].
    Saraux H
    J Fr Ophtalmol; 1988; 11(3):237-40. PubMed ID: 3418019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
    Park YC; Lim JK; Lee DK; Yi SD
    J Korean Med Sci; 1993 Oct; 8(5):334-40. PubMed ID: 8305141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm.
    Ainsworth JR; Kraft SP
    Ophthalmology; 1995 Dec; 102(12):2036-40. PubMed ID: 9098314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm.
    Kalra HK; Magoon EH
    Ophthalmic Surg; 1990 May; 21(5):335-8. PubMed ID: 2381655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of botulinum toxin in blepharospasm.
    Shorr N; Seiff SR; Kopelman J
    Am J Ophthalmol; 1985 May; 99(5):542-6. PubMed ID: 4003489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of botulinum toxin in blepharospasm and other facial spasms.
    Ruusuvaara P; Setälä K
    Acta Ophthalmol (Copenh); 1987 Jun; 65(3):313-9. PubMed ID: 3618155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of facial spasm with botulinum toxin. An interim report.
    Frueh BR; Musch DC
    Ophthalmology; 1986 Jul; 93(7):917-23. PubMed ID: 3763137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct injection of liposome-encapsulated doxorubicin optimizes chemomyectomy in rabbit eyelid.
    McLoon LK; Wirtschafter JD
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2561-7. PubMed ID: 10509650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections.
    Price J; Farish S; Taylor H; O'Day J
    Ophthalmology; 1997 May; 104(5):865-8. PubMed ID: 9160036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
    Chang LB; Tsai CP; Liao KK; Kao KP; Yuan CL; Yen DJ; Lin KP
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm.
    Albanese A; Colosimo C; Carretta D; Dickmann A; Bentivoglio AR; Tonali P
    Eur Neurol; 1992; 32(2):112-7. PubMed ID: 1563461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
    Kraft SP; Lang AE
    CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.